The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the world’s most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 30 years.
In compliance with applicable State regulatory authorities, COVID-19 vaccination is mandatory for all MSK staff. Staff are considered fully vaccinated upon completion of a primary vaccination series for COVID-19 (i.e., one dose of a single dose vaccine or a final dose of a multi-dose vaccine series). Exceptions from the COVID-19 vaccine requirement are permitted for those who request and receive an approved medical or fully remote exemption. Requests for medical exemption can take up to two weeks to review. Vaccination or an approved medical exemption is required to start work.
Note: Individuals are eligible to receive a COVID-19 booster two months after completion of a primary vaccination series for COVID-19. Because vaccine-induced immunity can wane over time, MSK continues to strongly urge all staff to get a COVID-19 booster as soon as they become eligible to maintain their protective immunity for a longer period.
The Marians laboratory’s long-standing interests have been in the nature of replication fork operations, the mechanisms of replication fork restart, and the results of collisions between the replication fork and transcription complexes and R-loops. Our approach is centered on biochemical reconstitution experiments using purified proteins and specialized templates to model these processes. We have recently shifted our primary focus from using bacterial proteins to using human proteins to develop these in vitro systems. (https://www.mskcc.org/research/ski/labs/kenneth-j-marians)
The laboratory is part of an exceptionally strong group of researchers investigating diverse aspects of genome integrity in the Molecular Biology Program of Memorial Sloan Kettering Cancer Center (https://www.mskcc.org/research-areas/programs-centers/molecular-biology).
Postdoctoral positions are available for appropriately trained, creative individuals who are interested in how human replication acts both as a genome stabilizer and, when corrupted, as a genome destabilizer. Extensive biochemical training is a must. Familiarity with mammalian overexpression systems is a plus.
Please submit an application with the following required documents:
Salary: $61,150 – $100,000
MSK is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration without regard to race, color, gender, gender identity or expression, sexual orientation, national origin, age, religion, creed, disability, veteran status or any other factor which cannot lawfully be used as a basis for an employment decision.
Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. Please tell us if you require accommodation to apply for a job or to perform your job. Examples of reasonable accommodation include making a change to the application process or work procedures, providing documents in an alternate format, using a sign language interpreter, or using specialized equipment.